Cutaneous field stimulation of sensory nerve fibers reduces itch without affecting contact dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 12, 2002, Pages 1195-1199

  Wallengren, Joanna ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contact allergy; Contact dermatitis; Cutaneous field stimulation nickel; Patch test; Prick test; Sensory nerves

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUTANEOUS FIELD STIMULATION; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; MALE; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; PRURITUS; SENSORY NERVE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; ANTIFUNGAL AGENTS; BENZALKONIUM COMPOUNDS; BENZOIC ACID; CROSS REACTIONS; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, IRRITANT; DRUG ERUPTIONS; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; NERVE FIBERS; NICKEL; PRURITUS; RADIOPHARMACEUTICALS; RECEPTORS, SENSORY; SKIN TESTS; TREATMENT OUTCOME; TUBERCULIN; URTICARIA;

EID: 0036950465     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.23709.x     Document Type: Article

References (17)

1. NILSSON HJ, LEVINSSON A, SCHOUENBORG J. Cutaneous field stimulation (CFS) a new powerful method to combat itch. Pain 1997;71:49-55.
2. WALLENGREN J, SUNDLER F. Cutaneous field stimulation (CFS) in treatment of severe localized itch. Arch Dermatol 2001;137:1323-1325.
3. WAHLGREN CF. Itch and atopic dermatitis. An overview. J Dermatol 1999;26:770-779.
4. JOHANSSON SGO, HOURIHANE JO'B, BOUSQUET J, et al. A revised nomenclature for allergy. An EAACI position statement from EAACI nomenclature task force. Allergy 2001;56:813-824.
5. WALLENGREN J, EKMAN R, MÖLLER H. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Dermatol Venereol (Stockh) 1986;66:23-28.
6. EKBLOM A, HANSSON P, FJELLNER B. The influence of extrasegmental mechanical vibratory stimulation and transcutaneous electrical nerve stimulation on histamine-induced itch. Acta Physiol Scand 1985;125:541-545.
7. WALLENGREN J, EKMAN R, SUNDLER F. Occurrence and distribution of neuropeptides in the human skin. Acta Derm Venereol (Stockh) 1987;67:185-192.
8. WALLENGREN J, HÅKANSON R. Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory mediated responses. Eu J Pharmacol 1987;143:267-273.
9. WALLENGREN J. Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reactions. Br J Dermatol 1991;124:324-328.
10. TORII H, HOSOI J, ASAHINA A, GRANSTEIN RD. Calcitonin gene-related peptide and Langerhans cell function. J Invest Dermatol Symp Proc 1997;1:82-86.
11. NOLANO M, SIMONE DA, WENDELSCHAFER-CRABB G, JOHNSON T, HAZEN E, KENNEDY WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 1999;81:135-145.
12. FITZGERALD M. Capsaicin and sensory neurons: a review. Pain 1983;15:109-130.
13. GIROLOMONI G, TIGELAAR RE. Capsaicin-sensitive primary sensory neurons are potent modulators of murine delayed-type hypersensitivity reactions. J Immunol 1990;145:1105-1112.
14. WALLENGREN J, EKMAN R, MÖLLER H. Capsaicin enhances allergic contact dermatitis in guinea pig. Contact Dermatitis 1991;24:30-34.
15. WALLENGREN. J. MÖLler H. The effect of capsaicin on some experimental inflammations in human skin. Acta Derm Venereol (Stockh) 1986;66:375-380.
16. LUNDEBERG L, MUTT V, NORDLING K. Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. Acta Dermatol Venereol 1999;79:178-182.
17. LUGER TA, SCHWARZ T. The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation. Allergy 1995;50:292-302.